Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Gratus Capital LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,148 shares of the medical research company’s stock, valued at approximately $1,112,000.
A number of other institutional investors and hedge funds have also bought and sold shares of A. AMG National Trust Bank grew its holdings in Agilent Technologies by 9.5% during the 3rd quarter. AMG National Trust Bank now owns 2,629 shares of the medical research company’s stock worth $320,000 after acquiring an additional 229 shares during the period. Ieq Capital LLC boosted its holdings in shares of Agilent Technologies by 67.9% during the 3rd quarter. Ieq Capital LLC now owns 8,986 shares of the medical research company’s stock worth $1,092,000 after buying an additional 3,633 shares in the last quarter. First Republic Investment Management Inc. grew its position in shares of Agilent Technologies by 3.1% during the 3rd quarter. First Republic Investment Management Inc. now owns 24,179 shares of the medical research company’s stock worth $2,939,000 after buying an additional 735 shares during the period. Illinois Municipal Retirement Fund lifted its position in shares of Agilent Technologies by 24.1% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 170,803 shares of the medical research company’s stock valued at $20,761,000 after acquiring an additional 33,177 shares during the period. Finally, Mutual Advisors LLC boosted its stake in Agilent Technologies by 1.4% during the third quarter. Mutual Advisors LLC now owns 6,638 shares of the medical research company’s stock worth $807,000 after acquiring an additional 89 shares in the last quarter.
Insider Transactions at Agilent Technologies
In related news, SVP Henrik Ancher-Jensen sold 29,500 shares of the stock in a transaction dated Wednesday, December 14th. The stock was sold at an average price of $155.78, for a total transaction of $4,595,510.00. Following the sale, the senior vice president now owns 70,793 shares of the company’s stock, valued at approximately $11,028,133.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Agilent Technologies news, SVP Henrik Ancher-Jensen sold 29,500 shares of the firm’s stock in a transaction on Wednesday, December 14th. The shares were sold at an average price of $155.78, for a total value of $4,595,510.00. Following the completion of the transaction, the senior vice president now directly owns 70,793 shares of the company’s stock, valued at approximately $11,028,133.54. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Padraig Mcdonnell sold 672 shares of the firm’s stock in a transaction dated Tuesday, December 13th. The shares were sold at an average price of $160.00, for a total value of $107,520.00. Following the completion of the sale, the vice president now directly owns 15,529 shares in the company, valued at approximately $2,484,640. The disclosure for this sale can be found here. Insiders sold 215,814 shares of company stock valued at $33,179,644 over the last three months.
Agilent Technologies Price Performance
Agilent Technologies stock opened at $155.92 on Monday. The company has a current ratio of 2.03, a quick ratio of 1.47 and a debt-to-equity ratio of 0.52. The business’s 50 day simple moving average is $151.96 and its 200 day simple moving average is $137.93. Agilent Technologies, Inc. has a 12 month low of $112.52 and a 12 month high of $160.26. The company has a market cap of $46.16 billion, a price-to-earnings ratio of 37.39, a PEG ratio of 2.76 and a beta of 1.07.
Agilent Technologies (NYSE:A – Get Rating) last announced its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.14. The company had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.76 billion. Agilent Technologies had a return on equity of 30.28% and a net margin of 18.31%. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.21 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.64 EPS for the current year.
Agilent Technologies announced that its Board of Directors has initiated a stock buyback program on Monday, January 9th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical research company to reacquire up to 4.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.
Agilent Technologies Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be given a dividend of $0.225 per share. The ex-dividend date of this dividend is Friday, December 30th. This represents a $0.90 annualized dividend and a dividend yield of 0.58%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s dividend payout ratio is currently 21.58%.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on A. Robert W. Baird raised their target price on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday, November 22nd. Cowen increased their target price on Agilent Technologies from $160.00 to $168.00 in a report on Tuesday, November 22nd. UBS Group raised their price objective on shares of Agilent Technologies from $152.00 to $170.00 and gave the company a “buy” rating in a research note on Tuesday, December 20th. KeyCorp upped their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a report on Tuesday, November 22nd. Finally, Evercore ISI increased their price objective on Agilent Technologies from $140.00 to $155.00 in a research note on Tuesday, November 22nd. Three investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $161.36.
Agilent Technologies Company Profile
(Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Recommended Stories
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Is Canadian Solar Too Hot to Handle?
- UiPath is the Blue-Collar AI Platform to Watch in 2023
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
